NAMA
TWST icon

Nikko Asset Management Americas’s Twist Bioscience TWST Stock Holding History

Nikko Asset Management Americas’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103M Sell
999,734
-496,365
-33% -$32.3M 1.33% 26
2026
Q1 		$71.1M Sell
1,496,099
-406,730
-21% -$18.2M 1.01% 31
2025
Q4 		$60.3M Sell
1,902,829
-217,377
-10% -$6.78M 0.7% 43
2025
Q3 		$59.6M Sell
2,120,206
-179,231
-8% -$5.43M 0.58% 45
2025
Q2 		$84.5M Sell
2,299,437
-116,361
-5% -$4.02M 0.84% 31
2025
Q1 		$94.8M Sell
2,415,798
-197,166
-8% -$8.88M 1.22% 22
2024
Q4 		$121M Sell
2,612,964
-247,883
-9% -$11.2M 1.32% 20
2024
Q3 		$129M Sell
2,860,847
-302,584
-10% -$14.4M 1.46% 21
2024
Q2 		$156M Sell
3,163,431
-387,882
-11% -$15.8M 1.8% 18
2024
Q1 		$122M Sell
3,551,313
-32,130
-0.9% -$1.16M 1.21% 22
2023
Q4 		$132M Buy
3,583,443
+99,511
+3% +$2.3M 1.27% 20
2023
Q3 		$70.4M Sell
3,483,932
-82,307
-2% -$1.81M 0.84% 30
2023
Q2 		$73M Buy
3,566,239
+164,325
+5% +$2.46M 0.77% 32
2023
Q1 		$50.6M Buy
3,401,914
+467,881
+16% +$10.3M 0.58% 37
2022
Q4 		$69.8M Buy
2,934,033
+114,137
+4% +$3.31M 1.01% 27
2022
Q3 		$87.4M Buy
2,819,896
+142,726
+5% +$6.06M 1.12% 23
2022
Q2 		$80.3M Buy
2,677,170
+300,885
+13% +$10.7M 0.99% 21
2022
Q1 		$108M Buy
2,376,285
+25,028
+1% +$1.39M 0.79% 30
2021
Q4 		$174M Buy
2,351,257
+205,147
+10% +$21.1M 0.92% 27
2021
Q3 		$217M Sell
2,146,110
-378,492
-15% -$43.3M 0.93% 30
2021
Q2 		$325M Buy
2,524,602
+461,438
+22% +$53.6M 1.27% 26
2021
Q1 		$256M Buy
2,063,164
+222,858
+12% +$33.8M 1.25% 24
2020
Q4 		$260M Buy
1,840,306
+223,928
+14% +$24.8M 1.48% 22
2020
Q3 		$117M Buy
1,616,378
+647,063
+67% +$40.3M 1.04% 34
2020
Q2 		$42.5M Buy
969,315
+163,609
+20% +$5.87M 0.56% 48
2020
Q1 		$24.6M Buy
+805,706
New +$21.7M 0.46% 58

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Nikko Asset Management Americas's TWST Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Twist Bioscience (TWST) stake by 33% in Q2 2026, selling an estimated $32.3M and leaving 999,734 shares worth $103M. The position accounts for 1.33% of the portfolio, ranked #26.

Nikko Asset Management Americas first reported a position in TWST in Q1 2020 and has held it in 26 quarters since. The position peaked at $325M in Q2 2021. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Nikko Asset Management Americas held 999,734 shares of Twist Bioscience worth $103M as of Q2 2026.
  • Nikko Asset Management Americas sold 496,365 Twist Bioscience shares in Q2 2026, an estimated $32.3M.
  • Twist Bioscience made up 1.33% of Nikko Asset Management Americas's portfolio in Q2 2026, its #26 holding.
  • Nikko Asset Management Americas first reported a position in Twist Bioscience in Q1 2020 and has held it in 26 quarters since.
  • Nikko Asset Management Americas's Twist Bioscience position peaked at $325M in Q2 2021.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.